Trxade Group to Report Third Quarter 2020 Results on Monday, October 26th at 5:00 p.m. Eastern Time

Rhea-AI Summary

Trxade Group (MEDS) will announce its third-quarter financial results on October 26, 2020, after market close. A conference call is scheduled for the same day at 5:00 p.m. Eastern time to discuss the results, with a Q&A session following. Interested participants should dial in at least 10 minutes early. A playback will be available through November 26, 2020. Trxade Group focuses on improving the affordability and accessibility of healthcare through its integrated platforms.

TAMPA, FL, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, October 26, 2020.

Management will host a conference call on Monday, October 26, 2020, at 5:00 p.m. Eastern time to discuss Trxade Group’s third quarter 2020 financial results. The call will conclude with Q&A from participants. To participate, please use the following information:

Q3 2020 Conference Call and Webcast
Date: Monday, October 26, 2020
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13711397
Webcast: http://public.viavid.com/index.php?id=141748

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

A playback of the call will be available through November 26, 2020. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13711397. A webcast will also be available for 30 days on the IR section of the Trxade Group website or by clicking the webcast link above.

About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (Nasdaq: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; (1) the Trxade B2B trading platform with around 11,800 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit us at www.trxade.com and www.bonumhealth.com.

Investor Relations:
Lucas Zimmerman
Senior Vice President
MZ Group - MZ North America
(949) 259-4987
MEDS@mzgroup.us
www.mzgroup.us

FAQ

When will MEDS release its third-quarter financial results?

Trxade Group (MEDS) will release its third-quarter financial results on October 26, 2020, after market close.

What time is the MEDS conference call scheduled for?

The conference call to discuss MEDS' third-quarter financial results is scheduled for October 26, 2020, at 5:00 p.m. Eastern time.

How can I participate in the MEDS conference call?

To participate in the MEDS conference call, dial 1-877-425-9470 in the U.S. or 1-201-389-0878 internationally, and use Conference ID 13711397.

Is there a playback option for the MEDS conference call?

Yes, a playback of the MEDS conference call will be available through November 26, 2020. Use the U.S. number 1-844-512-2921 or international number 1-412-317-6671 with the same conference ID.

What is the focus of Trxade Group, Inc. (MEDS)?

Trxade Group (MEDS) focuses on integrated drug procurement, delivery, and healthcare platforms to improve price transparency and accessibility of medical services.